Kevin Koch

Director & President and CEO

Director & President and CEO at Edgewise Therapeutics, Inc., filing insider transactions on 2026-08-12.

Total Purchases

—

0 transactions

Total Sales

$785K

3 transactions

Companies Traded

3 total filings

Active Since

2026-08-12

Last: 2026-08-12

Companies

Edgewise Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-12	EWTX	Sale	8,276	$43.66	$361K	53.4K	SEC ↗
2026-08-12	EWTX	Sale	8,782	$43.64	$383K	61.7K	SEC ↗
2026-08-12	EWTX	Sale	913	$44.33	$40K	52.5K